Vivos RDGL
OTC RDGL
$0.04 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Vivos (RDGL) Capital Expenditures (2009 - 2026)

Updated

Analysis

Vivos (RDGL) Capital Expenditures (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 437.00 Mn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 513.00 Mn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 255.00 Mn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 113.10 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 503.00 Mn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn 237.00 Mn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 180.00 Mn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 63.60 Mn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 141.00 Mn
10 Vivos 19.77 Mn 11.15 Mn -1,720.00 -396,949.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -396,949.00
Mar 31, 2026 151,205.00
Mar 31, 2017 2,800.00
Mar 31, 2013 9,754.00
Dec 31, 2012 -84,678.00
Dec 31, 2010 28,690.00
Dec 31, 2009 2.35 Mn
Mar 31, 2009 -2.58 Mn
API Access

Vivos Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RDGL&period=max&api_key=YOUR_API_KEY